Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The purpose of this study is to find out about the potential benefits and safety of brexpiprazole in children and adolescent participants, aged 5 to 17, with irritability associated with autism spectrum disorder.
Epistemonikos ID: 10b3d6d591fe5f63f67b56c3b9bcb5bd17d1e688
First added on: May 06, 2024